Economic Evaluation of Gemcitabine in Different Treatment Manner Combined with Cisplatin as First-line Chemotherapy for Advanced Non-small Cell Lung Cancer
- VernacularTitle:吉西他滨不同给药方法联合顺铂一线治疗晚期非小细胞肺癌的经济学评价
- Author:
Jianguo ZHAO
- Publication Type:Journal Article
- Keywords:
Non-small cell lung cancer;
Gemcitabine;
Cost-effectiveness analysis
- From:
China Pharmacy
1991;0(04):-
- CountryChina
- Language:Chinese
-
Abstract:
0.05) . Cost-effectiveness ratios were 52.89 and 211.53,respectively. CONCLUSION:Low-dose prolonged gemcitabine infusion combined with cisplatin regimen is economical one in the treatment of advanced NSCLC.
